Concepedia

Author

R. Benz

United States Food and Drug Administration

Also Known As

Benz, R Benz, R D Benz, R Daniel Benz, R. BENZ, R. Benz, R. D. Benz, R. Daniel Benz, R.D. Benz, R.Daniel Benz

94

Publications

2K

Citations

26

H-Index

89

Concepts

All Affiliations

United States Food and Drug AdministrationCenter for Drug Evaluation and ResearchUniversität UlmEnvironmental Protection AgencyCenter for Food Safety and Applied Nutrition
RB

About

R. Benz is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and toxicology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

20

1.4K

2

Public Health

9

9

538

3

Health Sciences

2

2

142

4

Engineering

1

1

57

5

Allergy

1

1

42

R. Benz

×

30

Publications

1.7K

Citations

23

H-Index

YearCitations

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

Edwin J. Matthews, Naomi L. Kruhlak, Michael C. Cimino,

Regulatory Toxicology and Pharmacology

2005

132

Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction.

Martin Wabitsch, Hans Hauner, E. Heinze,

The Journal of Clinical Endocrinology & Metabolism

1995

128

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods

Edwin J. Matthews, Naomi L. Kruhlak, Michael C. Cimino,

Regulatory Toxicology and Pharmacology

2005

96

Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

Joseph F. Contrera, Edwin J. Matthews, R. Benz

Regulatory Toxicology and Pharmacology

2003

93

(Q)SAR Modeling and Safety Assessment in Regulatory Review

Naomi L. Kruhlak, R. Benz, Hongfei Zhou,

Clinical Pharmacology & Therapeutics

2012

92

Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum.

Helga Moncayo, Roy Moncayo, R. Benz,

Journal of Clinical Investigation

1989

91

Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose

Joseph F. Contrera, Edwin J. Matthews, Naomi L. Kruhlak,

Regulatory Toxicology and Pharmacology

2004

88

Assessment of the Health Effects of Chemicals in Humans: I. QSAR Estimation of the Maximum Recommended Therapeutic Dose (MRTD) and No Effect Level (NOEL) of Organic Chemicals Based on Clinical Trial Data1

Edwin J. Matthews, Naomi L. Kruhlak, R. Benz,

Current Drug Discovery Technologies

2004

84

Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in Rodents

Edwin J. Matthews, Naomi L. Kruhlak, R. Benz,

Toxicology Mechanisms and Methods

2008

78

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

Edwin J. Matthews, Carling Ursem, Naomi L. Kruhlak,

Regulatory Toxicology and Pharmacology

2009

77

Page 1